Cipla Pharmaceutical Company

News, Pharma, Pharma Companies Add comments

Nov 242010

Useful Videos for Cipla Pharmaceutical Company

News & News Articles on: Cipla Pharmaceutical Company

Ranbaxy, Cipla Stocks on Roller Coaster Ride [Source: Bloggingstocks.com]
The company inked an agreement with India’s pharmaceutical producer Cipla to market Cipla’s over-the-counter and prescription drugs in Russia and the Ukraine. “Marketing of Cipla’s portfolio in Russia began in the recently-ended second fiscal quarter; the …
[Click here to Read the Full Article/NEWS]

Indian Pharmaceutical Industry – looking beyond generics Available through Bharatbook [Source: Asian Age]
Further gains are likely in Dr Reddy, Lupin, Cipla, Dabur and HLL. Ahead of the FPO of SCI … Gutsy traders can attempt buying in Reliance Infra and Reliance Power. Plethico Pharmaceuticals Ltd is a an emerging healthcarecompany with strong emphasis on …
[Click here to Read the Full Article/NEWS]

Research and Markets: Examine India’s Pharmaceuticals Indsutry with this 2H10 Report as the US Remains [Source: MoneyControl.com]
A study of the SBI Mutual Funds portfolio for the month of October 2010 showed that in the pharmaceuticals sector, it purchased Cipla, Lupin … where it sold Tata Power Company, NTPC and Power Grid Corporation, while it bought NHPC.
[Click here to Read the Full Article/NEWS]

Cipla Q2 net declines 5%; no decision yet on African investment [Source: Economic Times]
Companies across various sectors, including pharmaceuticals, steel … Sun Pharma and Lupin have posted good performance on the back of a revival in US markets. Cipla’s performance was helped by good show in the domestic market. Going forward, Sun Pharma …
[Click here to Read the Full Article/NEWS]

Silk Road to India: HDFC (HDB) and Dr. Reddy’s (RDY) [Source: Sify]
Tata Consultancy Services (down 2.1%), ONGC (down 1.9%), Cipla (down 1.3%) and BHEL (down 1.1% … Ranbaxy Laboratories is down with a loss of 1.5% at Rs 594 despite the company reporting better-than-expected results. Ranbaxy, controlled by Japan’s Daiichi …
[Click here to Read the Full Article/NEWS]

Markets to remain volatile due to F&O settlement [Source: Economic Times]
The only losers were NTPC (-0.87%), Sterlite (-0.23%) and L&T (-0.19%). 3:10 pm: Bafna Pharmaceuticals Ltd has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Finasteride 5 MG tablets. On BSE, the company’s …
[Click here to Read the Full Article/NEWS]